ARCHIVES

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

This article is from The Cancer Letter archive.

Vol. 13 No. 26 | June 26, 1987

Download PDF Visit The Full Archive

Related Articles

NCI to Host SBIR Investor Forum

November 7, 2014

Early Treatment with CMX001 Can Help Prevent CMV Infection

September 27, 2013

Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

June 6, 2014

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

Gonzalez-Angulo To Serve 10 Years In Poisoning Case

October 3, 2014

NCAB Approves CCP, Agrees To Compromise On Including Control

May 21, 1982